跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Rixathon - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Rixathon
Approved
STANDARD
Rixathon
Lek Pharmaceuticals D.D
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
7a02c5ff44433182
Company
Lek Pharmaceuticals D.D
Type
Standard
Approval Details
Approval Id
7a02c5ff44433182
Drug Approval Philippines Name
Rixathon
Product Name
Rixathon
Registration Number
BRP-110
Brand Name
Rixathon
Generic Name
Rituximab
Dosage Form
Concentrate For Solution For Infusion (IV)
Dosage Strength
500 mg/50 mL (10mg/mL)
Manufacturer
Lek Pharmaceuticals D.D
Importer
Sandoz Philippines Corporation
Distributor
Sandoz Philippines Corporation
Issuance Date
27 June 2022
Expiry Date
27 June 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
7a02c5ff44433182
Type
Standard
Back to Philippines FDA Approvals